首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Relationship of annual change in bone mineral density with extent of emphysematous lesions and pulmonary function in patients with COPD
【24h】

Relationship of annual change in bone mineral density with extent of emphysematous lesions and pulmonary function in patients with COPD

机译:慢性阻塞性肺病患者骨密度的年变化与肺气肿病变程度和肺功能的关系

获取原文
           

摘要

Background: Osteoporosis is a well-known comorbidity in COPD. It is associated with poor health status and prognosis. Although the exact pathomechanisms are unclear, osteoporosis is suggested to be either a comorbidity due to shared risk factors with COPD or a systematic effect of COPD with a cause–effect relationship. This study aimed to evaluate whether progression of osteoporosis is synchronized with that of COPD. Materials and methods: Data from 103 patients with COPD included in the Hokkaido COPD cohort study were analyzed. Computed tomography (CT) attenuation values of thoracic vertebrae 4, 7, and 10 were measured using custom software, and the average value (average bone density; ABD4,7,10) was calculated. The percentage of low attenuation volume (LAV%) for each patient was also calculated for evaluation of emphysematous lesions. Annual change in thoracic vertebral CT attenuation, which is strongly correlated with dual-energy X-ray absorptiometry-measured bone mineral density, was compared with that in FEV1.0 or emphysematous lesions. Results: In the first CT data set, ABD4,7,10 was significantly correlated with age ( ρ =–0.331; p =0.0006), body mass index (BMI; ρ =0.246; p =0.0136), St George’s Respiratory Questionnaire (SGRQ) activity score ( ρ =–0.248; p =0.0115), eosinophil count ( ρ =0.229; p =0.0198), and LAV% ( ρ =–0.372; p =0.0001). However, ABD4,7,10 was not associated with FEV1.0. After adjustment for age, BMI, SGRQ activity score, and eosinophil count, no significant relationship was found between ABD4,7,10 and LAV%. Annual change in ABD4,7,10 was not associated with annual change in LAV% or FEV1.0. Conclusion: Progression of osteoporosis and that of COPD are not directly related or synchronized with each other.
机译:背景:骨质疏松症是COPD中的一种众所周知的合并症。它与不良的健康状况和预后有关。尽管尚不清楚确切的发病机制,但骨质疏松症被认为是合并的疾病,原因是COPD具有共同的危险因素,或者是COPD与因果关系的系统性作用。这项研究旨在评估骨质疏松症的进展是否与COPD同步。材料和方法:分析北海道COPD队列研究中103例COPD患者的数据。使用定制软件测量胸椎4、7和10的计算机断层扫描(CT)衰减值,并计算平均值(平均骨密度; ABD 4,7,10 )。还计算了每个患者的低衰减体积百分比(LAV%),以评估气肿性皮损。将胸椎CT衰减的年度变化与双能X线骨密度仪测量的骨矿物质密度密切相关,与FEV 1.0 或气肿性病变的变化进行了比较。结果:在第一个CT数据集中,ABD 4,7,10 与年龄(ρ= –0.331; p = 0.0006),体重指数(BMI;ρ= 0.246; p = 0.0136),圣乔治呼吸问卷(SGRQ)活动评分(ρ= –0.248; p = 0.0115),嗜酸性粒细胞计数(ρ= 0.229; p = 0.0198)和LAV%(ρ= –0.372; p = 0.0001)。但是,ABD 4,7,10 与FEV 1.0 不相关。调整年龄,BMI,SGRQ活性评分和嗜酸性粒细胞计数后,ABD 4,7,10 与LAV%之间无显着关系。 ABD 4,7,10 的年度变化与LAV%或FEV 1.0 的年度变化无关。结论:骨质疏松症的进展与COPD的进展没有直接关系或彼此同步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号